abstract |
The document describes the compounds, compositions and methods for treating infections caused by flaviviruses, including HCV infections, namely the compound according to formula (40ii): or its pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form or polymorphic form. |